Craig focuses on helping clients protect and advance innovation through strategic patent development and counseling. He works with clients across the medical device, materials science, and life sciences sectors. More specifically, his experience encompasses neuromodulation systems, medical diagnostic equipment, cellular therapies, protein and gene diagnostics, pharmaceutical compositions, biologics, chemical polymers and other related technologies.
His clients frequently involve Craig early in the development of their inventions and provide guidance all the way through U.S. and international patent filing and prosecution. Additionally, Craig advises clients on broader intellectual property strategy. This includes preparing patentability, freedom-to-operate, invalidity, inventorship, infringement, and intellectual property due diligence opinions to support product development, investment decisions, and commercialization efforts.
His clients include universities, academic medical centers, start-up companies and other hubs of innovation. Craig assists these organizations as they navigate the transition from research to commercial application. As counsel and advocate for these and other innovators, Craig is accustomed to collaborating with technology transfer offices, research teams, and emerging companies to align intellectual property protection with long-term business goals.
He is a frequent lecturer on intellectual property and commercialization topics for clients, universities, and local and national organizations, including professional associations focused on technology transfer and innovation. Craig also serves as adjunct faculty at the Case Western Reserve University School of Law where he co-teaches a course on patent law and the biomedical sciences, as a reflection of his ongoing engagement in both the legal and scientific communities.
